Research

Engaging Research to Achieve Cancer Care Equity

asco quality care symposium

Racial Disparities in Performance Status

A new study by ConcertAI based on patient-reported outcomes makes another compelling case for addressing disparities in treatment outcomes and racially biased access to clinical trials – and for why a new research focus is imperative.

See Full Study
Methods

Retrospective Study of Self-Assessed Performance Status (ECOG)

Background
  • Clinical trials lack adequate number of racial minorities.
  • Performance status often a criterion for clinical research.
  • Poor performance status can exclude patients from clinical trial participation.
Patient in Study
0

  • 55.4% White
  • 38.0% Black
Results

Black patients overall reported higher average ECOG scores and greater difficulty performing daily functions than White patients.

Patients reporting not being able to take care of themselves

0%

Blacks

0%

Whites

Conclusion

Significant racial disparities exist in performance status at an initial visit to an oncology clinic and, for Black patients, could mean:
• Lower quality medical care pre-diagnosis
• Poorer outcomes
• Exclusion from clinical trials

ERACE Research Award

Announcing Award Recipients

We are pleased to announce that two grant applications have been accepted for the ERACE Research Award. The grant includes access to ERACE’s Real-world data (RWD) patient registry in support of cancer disparity research.

 

 

 

RESEARCH

2021 ASCO Annual Meeting

Read the latest research focused on racial differences in demographics, diagnoses and symptoms among oncology patients.

Assessment of differences in demographic characteristics and clinical diagnoses among black and white oncology patients with COVID

Read More

Differences by race in patient-reported symptoms during chemotherapy among women with early-stage, hormone receptor-positive breast cancer

Read More

See more ConcertAI  research published at the 2021 ASCO Annual Meeting.

Read More

Measurable Differences Among Minorities

 
2x

Black American women are 2x as likely to be diagnosed with triple negative breast cancer (TNBC) compared to white women.

0%

Black American men are 37% more likely to develop lung cancer than white men.

0%

Hispanic men are 10% less likely to be diagnosed with prostate cancer than non-Hispanic white men.

0%

American Indian/Alaska Native men are 40% more likely to have stomach cancer than white men, and 2x as likely to die from it.

0%

Liver cancer death rate is 60% higher in Asian Americans compared to whites.

Request a Demo